Author:
Yang Si-xing,Song Chao,Xiong Yun-he
Funder
Hubei Health Committee Science Foundation General Program
Applied Basic Research Programs of Wuhan Science and Technology Bureau
National Natural Science Funds of China
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Yang SX, Ye ZQ (2018) Reconsiderations of several key issues in the treatment of urolithiasis. Chin J Urol 39:644–646
2. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR, American Urological A (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324. https://doi.org/10.1016/j.juro.2014.05.006
3. Taguchi K, Cho SY, Ng AC, Usawachintachit M, Tan YK, Deng YL, Shen CH, Gyawali P, Alenezi H, Basiri A, Bou S, Djojodemedjo T, Sarica K, Shi L, Singam P, Singh SK, Yasui T (2019) The Urological Association of Asia clinical guideline for urinary stone disease. Int J Urol 26:688–709. https://doi.org/10.1111/iju.13957
4. Türk C, Petřík A, Sarica K, Seitz C, Knoll TJEU (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69:468–474
5. Duan ZQ, Zhu XY, Zhang Y, Wang YH, Liu YY, Guo HL, Xiao J, Wang ZR (2008) Effects of circadian gene mPer1 on therapeutic sensitivity of adriamycin. Sichuan Da Xue Xue Bao Yi Xue Ban 39:925–928
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献